Madrigal Pharmaceuticals, Inc. MDGL Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s change in AP?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported change in AP of $3.58M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s change in AP increased by 332.3% year-over-year, from -$1.54M to $3.58M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s change in AP?
- Over 2 years (2022 to 2025), Madrigal Pharmaceuticals, Inc.'s change in AP has grown at a 46.8% compound annual growth rate (CAGR), from $2.45M to $5.28M.
- What does change in AP mean?
- The change in money the company owes to its suppliers.
- How do you interpret change in AP?
- An increase can signal improved cash management or extended payment terms, while a decrease may indicate faster payments to suppliers.
- How does change in AP compare across companies?
- Analyzed alongside Days Payable Outstanding (DPO) to compare payment terms with industry standards.